Insider Transactions of Cadrenal Therapeutics, Inc.

Pham Quang X, CEO and Chairman of Cadrenal Therapeutics, Inc., reported the sale of 2,323 shares of common stock on June 3, 2026, for $4.26 per share. On June 4, 2026, an additional 3,898 shares were sold at $4.41 per share. On June 5, 2026, 2,064 shares were sold at $4.42 per share. These sales were conducted under a Rule 10b5-1 trading arrangement. Following these transactions, Pham Quang X directly owns 173,224 shares. Additionally, The PVBQ Living Trust, with Pham Quang X as Trustee, holds 200,000 shares, where his child is the sole beneficiary. The reported prices per share are weighted averages, with specific ranges provided in the footnotes.